Persistent Cancer Cells: The Deadly Survivors - Institut Gustave Roussy Access content directly
Journal Articles Cell Year : 2020

Persistent Cancer Cells: The Deadly Survivors


Persistent cancer cells are the discrete and usually undetected cells that survive cancer drug treatment and constitute a major cause of treatment failure. These cells are characterized by their slow proliferation, highly flexible energy consumption, adaptation to their microenvironment, and phenotypic plasticity. Mechanisms that underlie their persistence offer highly coveted and sought-after therapeutic targets, and include diverse epigenetic, transcriptional, and translational regulatory processes, as well as complex cell-cell interactions. Although the successful clinical targeting of persistent cancer cells remains to be realized, immense progress has been made in understanding their persistence, yielding promising preclinical results.
Fichier principal
Vignette du fichier
S009286742031391X.pdf (15.19 Mo) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-03493495 , version 1 (21-11-2022)


Attribution - NonCommercial



Shensi Shen, Stéphan Vagner, Caroline Robert. Persistent Cancer Cells: The Deadly Survivors. Cell, 2020, 183, pp.860 - 874. ⟨10.1016/j.cell.2020.10.027⟩. ⟨hal-03493495⟩
30 View
13 Download



Gmail Facebook X LinkedIn More